Correction of ketosis by suppression of lipolysis with 5-methylpyrazole-3-carboxylic acid in rats with established diabetic ketoacidosis.
D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D003921:Diabetes Mellitus, Experimental / Q000188:drug therapy* / Q000378:metabolism; D016883:Diabetic Ketoacidosis / Q000188:drug therapy* / Q000378:metabolism; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005990:Glycerol / Q000097:blood; D007657:Ketone Bodies / Q000097:blood; D008053:Lipid Mobilization / Q000187:drug effects*; D008297:Male; D011720:Pyrazoles / Q000494:pharmacology / Q000627:therapeutic use*; D051381:Rats
D001786:Blood Glucose; D005230:Fatty Acids, Nonesterified; D007657:Ketone Bodies; D011720:Pyrazoles; D005990:Glycerol